Edition:
United Kingdom

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

18.17USD
18 Apr 2019
Change (% chg)

$-0.21 (-1.14%)
Prev Close
$18.38
Open
$18.32
Day's High
$18.57
Day's Low
$17.51
Volume
429,484
Avg. Vol
615,274
52-wk High
$22.38
52-wk Low
$6.31

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Douglass Given

66 2013 Chairman of the Board

Christopher Anzalone

49 2007 President, Chief Executive Officer, Director

Kenneth Myszkowski

52 2010 Chief Financial Officer

Bruce Given

64 2011 Chief Operating Officer

Patrick O'Brien

55 2015 General Counsel